A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370)
Clinical trial NCT02788279 · COMPLETED
Trial details
- NCT number
- NCT02788279
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-05
- Primary completion
- 2018-03-09
- Enrollment
- 363
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.